Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Radiation Injuries 1Prostatic Neoplasms 1Erectile Dysfunction 1

Interventions

Radiotherapy 12Amifostine 7Cisplatin 6Etoposide 3Carboplatin 3Bevacizumab 3Radiotherapy, Intensity-Modulated 2Radiation 2Paclitaxel 2Heavy Ion Radiotherapy 2Fluorouracil 2sargramostim 1lithium sulfate 1Vincristine 1Surgical Procedures, Operative 1Steroids 1Selenomethionine 1Rituximab 1Protons 1Proton Therapy 1Procarbazine 1Physical Therapy Modalities 1Photons 1Palonosetron 1Olanzapine 1Methylprednisolone 1Methotrexate 1Mental Status and Dementia Tests 1Melatonin 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Radiation Injuries × ArginMax × Clear all
NCT01105130 2021-09-28

L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivors

Wake Forest University Health Sciences

Phase 2 Completed
140 enrolled 13 charts
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡